In recent trading, shares of Biomea Fusion Inc (Symbol: BMEA) have crossed above the average analyst 12-month target price of $41.50, changing hands for $41.80/share. When a stock reaches the target ...
BIOMEA FUSION ($BMEA) is expected to release its quarterly earnings data on Tuesday, April 1st after market close, per Finnhub. Analysts are expecting revenue of $0 ...
Fusion Pharmaceuticals stands as the final feasible option, poised to serve as a cornerstone for a major pharmaceutical company. Raymond James upgraded Fusion Pharmaceuticals from Outperform to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results